These 3 Dividend Stocks Are Now Yielding Up to 20%
The coronavirus pandemic is having a significant impact on the markets. This month, the Dow Jones dropped below 20,000 -- the lowest it's been in three years. And when share prices fall, dividend yields rise.
For dividend investors, it could be an opportune time to buy. But investors still need to be careful as a high dividend may not be sustainable. Let's take a look at three high-yielding stocks to see whether they're good buys today, or if investors should steer clear of them:
AbbVie (NYSE: ABBV) is down about 20% since the start of 2020. That's stronger than the S&P 500, which entering trading on Friday was down 26%. The healthcare stock's quarterly dividend of $1.18 is now yielding 6.6% annually. The company has raised its payouts by 195% since the stock began trading in 2013. It's a Dividend Aristocrat, as its payouts have increased for more than 25 years including AbbVie's time as part of Abbott Laboratories (NYSE: ABT).
Source Fool.com
